|
|
Volumn 4, Issue 8, 2013, Pages 1126-1127
|
|
A new achilles heel in breast cancer?
a
a
a
EPFL
(Switzerland)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENOSUMAB;
ESTROGEN;
ESTROGEN RECEPTOR ALPHA;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
OSTEOCLAST DIFFERENTIATION FACTOR;
PROGESTERONE;
PROGESTERONE RECEPTOR;
PROGESTERONE RECEPTOR MODULATOR;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
BREAST CANCER;
BREAST CARCINOGENESIS;
BREAST DEVELOPMENT;
CANCER RISK;
CELL PROLIFERATION;
DRUG MECHANISM;
EDITORIAL;
EX VIVO STUDY;
GYNECOLOGIC DISEASE;
HORMONE ACTION;
HORMONE SUBSTITUTION;
HUMAN;
MENSTRUAL CYCLE;
NONHUMAN;
PARACRINE SIGNALING;
UNSPECIFIED SIDE EFFECT;
ANIMALS;
BREAST NEOPLASMS;
CELL GROWTH PROCESSES;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
MICE;
RANK LIGAND;
RECEPTORS, PROGESTERONE;
RISK FACTORS;
SIGNAL TRANSDUCTION;
|
|
EID: 84884332044
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.1178 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
